Interaction of common azole antifungals with P glycoprotein

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 1, 2002, Pages 160-165

  Wang, E J ^a   Lew, K ^a   Casciano, C N ^a   Clement, R P ^a   Johnson, W W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; CYCLOSPORIN; FLUCONAZOLE; GLYCOPROTEIN P; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; DRUG DISPOSITION; DRUG INHIBITION; DRUG PROTEIN BINDING; EMBRYO; EUKARYOTIC CELL; GENE OVEREXPRESSION; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROKARYOSIS; PROTEIN TRANSPORT;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIFUNGAL AGENTS; AZOLES; CELL LINE; HYDROLYSIS; MICE; P-GLYCOPROTEIN;

EID: 0036135397     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.1.160-165.2002     Document Type: Article

References (40)

1. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein
2. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL
3. Efficacy and pharmacokinetics of simvastatin in heart transplant recipients
4. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: Application to lens ATPases
5. 3H]verapamil radioligand-binding assay
6. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis
7. The role of passive transbilayer drug movement in multidrug resistance and its modulation
8. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane
9. P-glycoprotein-a mediator of multidrug resistance in tumour cells
10. Biochemistry of multidrug resistance mediated by the multidrug transporter
11. P-glycoprotein and multidrug resistance
12. The mouse multidrug resistance gene family: Structural and functional analysis
13. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole
14. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia
15. Itraconazole decreases renal clearance of digoxin
16. Itraconazole increases plasma concentrations of quinidine
17. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
18. Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells
19. Rhabdomyolysis in patients treated with simvastatin and cyclosporin: Role of hepatic cytochrome P450 system activity
20. Current management of fungal infections
21. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier
22. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
23. Simvastatin, but not pravastatin, is very susceptible to interact with the CYP3A inhibitor itraconazole
24. Multiple-drug resistance in human cancer
25. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors
26. A general pattern for substrate recognition by P-glycoprotein
27. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein
28. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein
29. Ketoconazole effectively reverses multidrug resistance in highly resistant KB cells
30. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
31. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs
32. Effects of the antifungal agents on oxidative drug metabolism: Clinical relevance
33. Itraconazole and multidrug resistance: Possible effects on remission rate and disease-free survival in acute leukemia
34. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein
35. Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency
36. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: Evidence for half-of-the-sites reactivity
37. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein
38. A model for the prediction of digoxin-drug interactions at the renal tubular cell level
39. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds
40. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats